Business Insider
Amgen’s (AMGN) closely watched cardiovascular drug candidate lost a major rival on Sept. 4, when Novartis (NVS) announced that its pelacarsen trial failed to...
Hi, what are you looking for?
On Oct. 28, before earnings, I covered Morgan Stanley‘s preview of Shopify: sales were booming, and a holiday test was coming. And I find...
Paying for healthcare in America is complicated enough without having to figure out why the same prescription can cost more from one refill to...
For years, Nike (NKE) was my default whenever I needed a new pair of tennis shoes. But recently, I switched to On Cloud (ONON)...
More than 2 million shares in one of the world’s most valuable publicly traded companies are heading to children’s investment accounts, raising a tax...
Amgen’s (AMGN) closely watched cardiovascular drug candidate lost a major rival on Sept. 4, when Novartis (NVS) announced that its pelacarsen trial failed to...
While it is common practice for a new carrier to start advertising and selling tickets months before it has officially commenced operations, doing this...
Every restaurant owner learns the same lesson early. The cheapest growth comes from filling tables you already pay for, not from leasing a second...
Fear is the easiest thing in finance to sell, and the hardest to time. For more than a decade, Robert Kiyosaki has told readers...
Warren Buffett just wrapped up one of the longest runs in American business history. On Sept. 18, the 96-year-old stepped down as chairman of...
Family businesses eventually hit the same awkward question: who gets the keys when the founder steps away? Most founders answer with their heart. The...